These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6740018)

  • 41. Clinical and pathological study of asymptomatic HBsAg carriers in Chile.
    Velasco M; González-Cerón M; de la Fuente C; Ruiz A; Donoso S; Katz R
    Gut; 1978 Jun; 19(6):569-71. PubMed ID: 680591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunoglobulins and antibodies in the blood serum of blood donors - HBsAg carriers].
    Chrostowska H; Zółtowska A
    Pol Tyg Lek; 1980 Nov; 35(45):1721-3. PubMed ID: 7220371
    [No Abstract]   [Full Text] [Related]  

  • 43. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Morphological changes in the liver of patients with pulmonary tuberculosis--carriers of hepatitis B virus].
    Arifkhanova SI; Mukhtarov DZ
    Probl Tuberk; 1990; (8):63-6. PubMed ID: 2255705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Incidence of hepatic disease in australia antigen carriers (author's transl)].
    Procházka V; Pohlídalová L; Fischer O
    Cas Lek Cesk; 1974 Mar; 113(13):396-401. PubMed ID: 4434400
    [No Abstract]   [Full Text] [Related]  

  • 47. [Incidence of chronic liver diseases in HBsAg positive donors without symptoms].
    Wesdorp IC; Bartelsman JF; Hengeveld P; Den Hartog Jager FC; Jöbsis AC; Grijm R
    Ned Tijdschr Geneeskd; 1979 Jun; 123(24):1004-9. PubMed ID: 471084
    [No Abstract]   [Full Text] [Related]  

  • 48. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
    Andreani T; Serfaty L; Mohand D; Dernaika S; Wendum D; Chazouillères O; Poupon R
    Clin Gastroenterol Hepatol; 2007 May; 5(5):636-41. PubMed ID: 17428739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Importance of biochemical tests in donor selection].
    Khukhlovich PA; Braginskiĭ DM; Sergeeva NA; Tovstyko OI; Paktoris EA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):45-6. PubMed ID: 7367411
    [No Abstract]   [Full Text] [Related]  

  • 51. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical, serological and molecular characteristics of 471 hepatitis B virus carriers.
    Bar-Shany S; Shohat T; Tur-Kaspa R; Slepon R; Heering S; Lerman Y; Green M; Gilon E
    Isr J Med Sci; 1994 Apr; 30(4):263-6. PubMed ID: 8175326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Present situation of hepatitis B in Chile].
    Pereira S A; Valenzuela B MT; Mora J; Vera L
    Rev Med Chil; 2008 Jun; 136(6):725-32. PubMed ID: 18769828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The relationship between histologic characteristics of the liver and serologic markers in asymptomatic HBsAg carriers].
    Zhang YL
    Zhonghua Yi Xue Za Zhi; 1983 Dec; 63(12):747-9. PubMed ID: 6426747
    [No Abstract]   [Full Text] [Related]  

  • 56. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 57. The relationship of blood groups and hepatitis B virus antigen carrier state.
    Kiango JS; Missingo R; Mzula E
    East Afr Med J; 1982 Dec; 59(12):816-8. PubMed ID: 6820942
    [No Abstract]   [Full Text] [Related]  

  • 58. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The majority of hepatitis B carriers are not on regular surveillance in Singapore.
    Wai CT; Mak B; Chua W; Lim SG
    Singapore Med J; 2004 Sep; 45(9):423-6. PubMed ID: 15334285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.